KCT0002908招募中未知
Optimal Duration of antiplatelet Therapy after Bioresorbable Vascular Scaffold Implantation to Reduce Late Coronary Arterial Thrombotic Events : BVS-LATE trial
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 2,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19(Year) 至 o Limit（—）
- 性别
- All
入选标准
- •Age 19 and more
- •On dual or triple antiplatelet therapy and between 12months and 14months from Bioresorbable Vascular Scaffold implantation
- •No history of death, serious myocardial infarction, stroke, repeat revascularization, or major bleeding
排除标准
- •Contraindication to antiplatelet therapy
- •Need to continue clopidogrel due to stroke, peripheral disease, significant carotid disease or recent acute coronary syndrome
- •Major bleeding history or bleeding diathesis
- •Life expentancy less than 1year due to non-cardiac disease
研究者
相似试验
已完成
4 期
Optimal Duration of Antiplatelet Therapy After Bioresorbable Vascular Scaffold Implantation to Reduce Late Coronary Arterial Thrombotic EventsPercutaneous Transluminal Coronary AngioplastyCoronary DiseaseNCT02939872Seung-Jung Park238
进行中（未招募）
1 期
Optimal duration of dual anti-platelet therapy in patients undergoing endovascular revascularization of the superficial femoral artery.Patients with diagnosis of lower limbs PAOD, ranging from stage 2 to 5 according to Rutherford classification and lesions of the SFA treated by endovascular revascularizationMedDRA version: 20.0Level: LLTClassification code 10016430Term: Femoral artery stenosisSystem Organ Class: 100000004866EUCTR2018-000532-94-ITFONDAZIONE I.R.C.C.S. POLICLINICO SAN MATTEO78
进行中（未招募）
不适用
Optimal duration of dual antiplatelet therapy after stent-assisted coiling of unruptured intracranial aneurysms: A prospective randomized multicenter trialDiseases of the circulatory systemKCT0006651Seoul National University Bundang Hospital528
招募中
不适用
Appropriate Duration of Anti-Platelet straTegy in patients with advance Chronic Kideny Disease after new generation drug eluting stents (ADAPT-CKD)KCT0005775Yonsei University Health System, Severance Hospital900
尚未招募
不适用
Effect of potent P2Y12 inhibitor monotherapy after double antiplatelet therapy for 1 month after PCI in ACS patientsDiseases of the circulatory systemKCT0006861Chonnam National University Hospital2,000